華瑞股份(300626.SZ):控股股東擬為公司提供不超1.5億元中期借款
格隆匯 1 月 26日丨華瑞股份(300626.SZ)公佈,為支持公司生產經營發展,提高公司融資效率,降低融資成本,公司於2021年1月26日召開了第三屆董事會第十四次會議,審議通過了《關於向控股股東借款暨關聯交易的議案》,與控股股東梧州市東泰國有資產經營有限公司(“梧州東泰”)簽訂了《借款協議》。梧州東泰擬為公司提供不超過人民幣1.5億元的中期借款,借款年利率為放款日的中國人民銀行同期銀行貸款利率,借款期限為自合同生效之日起三年。授權公司董事長鄭偉或其授權人在額度內,具體辦理業務時簽署相關合同文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.